Patients' Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.

Bidur BanjaraNabin PoudelKimberly B Garza Salisa C Westrick Heather P WhitleyDavid ReddenSurachat Ngorsuraches

Published in: Patient preference and adherence (2022)

T2DM patients placed different preference weights or importance across SGLT-2i and GLP-1 RA attributes. Preference heterogeneity was found among patients with different ages and numbers of comorbidities.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
rheumatoid arthritis
single cell
disease activity
insulin resistance
glycemic control